RGD Peptide–Albumin Conjugate for Endothelization of Electrospun Materials


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

To improve the endothelization of 3D matrices produced by electrospinning we propose adding cyclo(RGDfC) peptide conjugated to human serum albumin (HSA) (HSA-c(RGDfC)) to the electrospinning solution. HSA-c(RGDfC) has been prepared using a bifunctional linker with N-hydroxysuccinimide and maleimide groups, and the product has been confirmed by 1Н NMR spectroscopy. Electrospun matrices have been fabricated from the solutions of 3% polyurethane Tecoflex EG-80A with 10% HSA and 0.01–1.3% HSA–c(RGDfC) (relative to Tec) in 1,1,1,3,3,3-hexafluoro-2-propanol. The presence of HSA and the cyclo(RGDfC) peptide on the surface of electrospun matrices has been confirmed by FTIR spectroscopy. The structure of matrices has been examined by scanning electron microscopy. The ability of the matrices to facilitate the adhesion of primary human umbilical vein endotheliocytes (HUVECs) has been studied. The presence of HSA–c(RGDfC) conjugate in the matrices enhanced cellular adhesion in a dose dependent manner with a maximum effect at 1% HSA-c(RGDfC).

作者简介

A. Cherepanova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

编辑信件的主要联系方式.
Email: a_cher@niboch.nsc.ru
俄罗斯联邦, Novosibirsk, 630090; Novosibirsk, 630055

D. Akisheva

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences

Email: a_cher@niboch.nsc.ru
俄罗斯联邦, Novosibirsk, 630090

T. Popova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
俄罗斯联邦, Novosibirsk, 630090; Novosibirsk, 630090

B. Chelobanov

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
俄罗斯联邦, Novosibirsk, 630090; Novosibirsk, 630090

Yu. Chesalov

Boreskov Institute of Catalysis, Federal Research Center, Siberian Branch, Russian Academy of Sciences

Email: a_cher@niboch.nsc.ru
俄罗斯联邦, Novosibirsk, 630090

T. Godovikova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Novosibirsk State University

Email: a_cher@niboch.nsc.ru
俄罗斯联邦, Novosibirsk, 630090; Novosibirsk, 630090

A. Karpenko

Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: a_cher@niboch.nsc.ru
俄罗斯联邦, Novosibirsk, 630055

P. Laktionov

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences; Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation

Email: a_cher@niboch.nsc.ru
俄罗斯联邦, Novosibirsk, 630090; Novosibirsk, 630055


版权所有 © Pleiades Publishing, Ltd., 2019
##common.cookie##